Search results for “Mucolipidosis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 440 patents, we discovered top 119 key players by total patent application. Merck Patent GmbH, AstraZeneca Pharmaceutical Co., Ltd., Bayer HealthCare AG are dominant in this area. They take 22.27% of the total patent filing.
Merck Patent GmbH
Hessen, Germany
Patent: 47
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 32
Bayer HealthCare AG
Nordrhein-Westfalen, Germany
Patent: 19
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 15
Laboratoires Fournier SAS
France
Patent: 14
Merck & Co., Inc.
New Jersey, United States
Patent: 13
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 13
Bristol Myers Squibb Co.
New York, United States
Patent: 11
Arena Pharmaceuticals, Inc.
California, United States
Patent: 11
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
IntraBio Ltd.
United Kingdom
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 13 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Genzyme Corp., Samsung Life Public Welfare Foundation, The General Hospital Corp. take 46.15% of patent filing during this period.
Genzyme Corp.
Massachusetts, United States
Patent: 2
Samsung Life Public Welfare Foundation
South Korea
Patent: 2
The General Hospital Corp.
Massachusetts, United States
Patent: 2
Eli Lilly & Co.
Indiana, United States
Patent: 1
Gmax Biopharm LLC
Zhejiang Sheng, China
Patent: 1
Janssen Pharmaceutica NV
Antwerpen, Belgium
Patent: 1
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 1
Department of Health & Human Services
Australia
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 13 patents in last 5 years, we discover 4 new entrants. The General Hospital Corp., Gmax Biopharm LLC, Department of Health & Human Services are the most active new entrants in this area.
The General Hospital Corp.
Massachusetts, United States
Patent: 2
Gmax Biopharm LLC
Zhejiang Sheng, China
Patent: 1
Department of Health & Human Services
Australia
Patent: 1
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 44 patents, we discovered top 16 universities and scientific research institutions by total patent application. North Carolina State University, Technische Universität München, Universidad Nacional Autónoma de México are dominant in this area. They take 43.18% of the total patent filing.
North Carolina State University
North Carolina, United States
Patent: 6
Technische Universität München
Bayern, Germany
Patent: 2
Universidad Nacional Autónoma de México
Distrito Federal, Mexico
Patent: 2
University of Poitiers
France
Patent: 2
Huazhong University of Science & Technology
Hubei Sheng, China
Patent: 2
The University of Exeter
Devon, United Kingdom
Patent: 2
Kagawa University
Kagawa-ken, Japan
Patent: 2
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1
University of Rochester
New York, United States
Patent: 1
University of British Columbia
British Columbia, Canada
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: